Thrombolysis with recombinant tissue plasminogen activator (rtPA) for treatment of acute ischaemic stroke

Witold Palasik

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Abstracting and indexing Contact Instructions for authors

9/2006
vol. 9

Send email

Copy url:

abstract:

Thrombolysis with recombinant tissue plasminogen activator (rtPA) for treatment of acute ischaemic stroke

Witold Palasik

Przew Lek 2006; 9: 72-76

Online publish date: 2006/11/22

View full text Get citation

Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) for acute ischaemic stroke has been proved to be effective when given within 3 h of onset of stroke symptoms. Unfortunately, partly due to this time limit, fewer than 10% of stroke patients can be treated with tPA. The positive results of the newest study assessing the potential for increased tPA utilization with a theoretical time limit of 6 hours could be a huge chance for people with acute stroke. We would like to present the newest results and new methods of treatment recombinant tissue plasminogen activator (rtPA) for acute ischaemic stroke.

keywords:

Thrombolysis with recombinant tissue plasminogen activator (rtPA) for treatment of acute ischaemic stroke

Witold Palasik

ischaemic stroke, thrombolysis, rtPA